Joincare Pharmaceutical Group Industry Co., Ltd. Class ASSE: 600380

"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance Briefing

Sep 18, 2026 · Issued by Joincare Pharmaceutical Group Industry Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 18, 2026

Announcement on Outline of the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Joincare Pharmaceutical Group Industry Co., Ltd. Class A

"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Change of Chairman and Adjustment of Members of Special Committees of the Board of DirectorsSep 12
"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on the Interim Profit Distribution Proposal for 2026Sep 5
"Joincare Pharmaceutical Group Industry Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 25
"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Progress in Providing Guarantee for Controlled SubsidiaryAug 5

All Joincare Pharmaceutical Group Industry Co., Ltd. Class A news releases